Neumora Therapeutics Inc....

NASDAQ: NMRA · Real-Time Price · USD
1.62
0.04 (2.53%)
At close: Aug 15, 2025, 3:59 PM
1.69
4.32%
After-hours: Aug 15, 2025, 05:24 PM EDT

Neumora Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 668K 2.7M 1.55M
Gross Profit
n/a -668K -2.7M -1.55M
Operating Income
-263.46M -188.19M -135.87M -237.32M
Interest Income
19.93M 16.61M 4.56M n/a
Pretax Income
-243.61M -235.66M -130.9M -237.31M
Net Income
-243.79M -235.93M -130.9M -237.31M
Selling & General & Admin
62.54M 44.81M 31.12M 24.55M
Research & Development
200.93M 142.72M 104.75M 212.78M
Other Expenses
n/a n/a 405K 11K
Operating Expenses
263.46M 187.53M 135.87M 237.32M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -668K n/a n/a
Cost & Expenses
n/a 188.19M 135.87M 237.32M
Income Tax Expense
178K 268K n/a 301.44K
Shares Outstanding (Basic)
159.38M 158.83M 151.95M 151.95M
Shares Outstanding (Diluted)
159.38M 158.83M 151.95M 151.95M
EPS (Basic)
-1.53 -1.49 -0.86 -1.56
EPS (Diluted)
-1.53 -1.49 -0.86 -1.56
EBITDA
-242.98M -187.53M -135.28M -236.78M
EBIT
-243.61M -188.19M n/a -237.32M
Depreciation & Amortization
631K 668K 2.7M 1.55M